Our group recently investigated some potent AGE inhibitors, and during the study, we found silver nanoparticles (AgNPs) significantly and concentration-dependently inhibited AGE formation, which suggested they can be considered a candidate for the treatment of diabetes and diabetes-associated problems [85]. The gene discussed is RENBP; the disease is diabetes mellitus.